CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: abexinostat
Accession: CHEBI:92223
browse the term
Definition: A 1-benzofuran substituted by {2-[4-(hydroxycarbamoyl)phenoxy]ethyl}aminocarbonyl and (dimethylamino)methyl groups at positions 2 and 3, respectively. It is a potent pan-HDAC inhibitor whose major target is HDAC1 (Ki = 7 nM).
Synonyms: related_synonym: 3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide; 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)-oxomethyl]phenoxy]ethyl]-2-benzofurancarboxamide; 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide; CRA 24781; CRA-024781; Formula=C21H23N3O5; InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25); InChIKey=MAUCONCHVWBMHK-UHFFFAOYSA-N; PCI-24781; PZP-115891; PZP115891; S-78454; S78454; SMILES=CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC1=CC=C(C=C1)C(=O)NO; abexinostatum
xref: AGR:IND605480874; CAS:783355-60-2; DrugBank:DB12565; HMDB:HMDB0256171; KEGG:D10060; LINCS:LSM-2269
xref_mesh: MESH:C512352
xref: PMCID:PMC4144576; PMID:16731764; PMID:18006784; PMID:18042714; PMID:19417021; PMID:19417023; PMID:20145726; PMID:20461381; PMID:21508354; PMID:22326466; PMID:23724141; PMID:23737346; PMID:23790467; PMID:23977108; PMID:24312289; PMID:25110436; PMID:25505847; PMID:25520806; PMID:25782916; PMID:26750740; PMID:27095947; PMID:27271328; PMID:28915585; PMID:32534122; PMID:33500709; PMID:34696786; PMID:38378603; Wikipedia:Abexinostat
G
Brca2
BRCA2, DNA repair associated
decreases expression
ISO
abexinostat results in decreased expression of BRCA2 mRNA
CTD
PMID:18042714
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Casp3
caspase 3
multiple interactions
ISO
[Bortezomib co-treated with abexinostat] results in increased activity of CASP3 protein
CTD
PMID:19417023
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases cleavage
ISO
Bortezomib promotes the reaction [abexinostat results in increased cleavage of CASP8 protein]
CTD
PMID:19417023
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases cleavage
ISO
Bortezomib promotes the reaction [abexinostat results in increased cleavage of CASP9 protein]
CTD
PMID:19417023
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
ISO
abexinostat results in decreased expression of CCL3 mRNA
CTD
PMID:19417023
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl7
C-C motif chemokine ligand 7
decreases expression
ISO
abexinostat results in decreased expression of CCL7 mRNA
CTD
PMID:19417023
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
Bortezomib promotes the reaction [abexinostat results in increased expression of CDKN1A protein]
CTD
PMID:19417023
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
ISO
abexinostat results in increased expression of GADD45G mRNA
CTD
PMID:18042714
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
abexinostat promotes the reaction [Bortezomib results in increased expression of HMOX1 mRNA] abexinostat results in increased expression of HMOX1 mRNA
CTD
PMID:19417023
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmox2
heme oxygenase 2
decreases expression multiple interactions
ISO
abexinostat results in decreased expression of HMOX2 mRNA abexinostat promotes the reaction [Bortezomib results in decreased expression of HMOX2 mRNA]
CTD
PMID:19417023
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions decreases expression
ISO
Bortezomib promotes the reaction [abexinostat results in decreased expression of IKBKB mRNA]
CTD
PMID:19417023
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions decreases expression
ISO
[Bortezomib co-treated with abexinostat] results in decreased expression of MYC mRNA; Bortezomib promotes the reaction [abexinostat results in decreased expression of MYC protein]
CTD
PMID:19417023
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
abexinostat results in decreased expression of NFKB1 mRNA
CTD
PMID:19417023
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
[Bortezomib co-treated with abexinostat] results in increased activity of PARP1 protein; quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [abexinostat results in increased cleavage of PARP1 protein]
CTD
PMID:18042714 PMID:19417023
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Rad51
RAD51 recombinase
decreases expression
ISO
abexinostat results in decreased expression of RAD51 mRNA; abexinostat results in decreased expression of RAD51 protein
CTD
PMID:18042714
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Relb
RELB proto-oncogene, NF-kB subunit
decreases expression
ISO
abexinostat results in decreased expression of RELB mRNA
CTD
PMID:19417023
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Txn2
thioredoxin 2
decreases expression multiple interactions
ISO
abexinostat results in decreased expression of TXN2 mRNA abexinostat promotes the reaction [Bortezomib results in decreased expression of TXN2 mRNA]
CTD
PMID:19417023
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd2
thioredoxin reductase 2
decreases expression multiple interactions
ISO
abexinostat results in decreased expression of TXNRD2 mRNA abexinostat promotes the reaction [Bortezomib results in decreased expression of TXNRD2 mRNA]
CTD
PMID:19417023
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all